Collegium Pharmaceutical
COLL
168 hedge funds and large institutions have $605M invested in Collegium Pharmaceutical in 2022 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 55 increasing their positions, 47 reducing their positions, and 22 closing their positions.
8,256% more call options, than puts
Call options by funds: $1.34M | Put options by funds: $16K
55% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 22
17% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 47
7% more funds holding
Funds holding: 157 → 168 (+11)
3.45% more ownership
Funds ownership: 107.24% → 110.69% (+3.4%)
6% less capital invested
Capital invested by funds: $646M → $605M (-$40.3M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$28.6M |
| 2 |
Millennium Management
New York
|
+$8.07M |
| 3 |
TA
Tamarack Advisers
Carlsbad,
California
|
+$3.53M |
| 4 |
MOACM
Mutual of America Capital Management
New York
|
+$2.41M |
| 5 |
BlackRock
New York
|
+$1.62M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
-$7.62M |
| 2 |
MFIMFI
Mesirow Financial Investment Management - Fixed Income
Chicago,
Illinois
|
-$5.66M |
| 3 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$4.91M |
| 4 |
Renaissance Technologies
New York
|
-$2.75M |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$2.49M |
COLL Hedge Fund Activity: Q3 2022 in Review
168 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q3 2022, worth a combined $605M — down 6.2% from $646M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new COLL positions and 22 closed out — a net gain of 12 holders — while 55 added to existing stakes and 47 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $28.6M. The largest seller was Royce & Associates, cutting an estimated $7.62M.
- 168 institutional investors held Collegium Pharmaceutical (COLL) as of Q3 2022, up from 157 in Q2 2022.
- Funds reported $605M of Collegium Pharmaceutical stock for Q3 2022, down 6.2% quarter-over-quarter.
- 34 funds opened new Collegium Pharmaceutical positions in Q3 2022 and 22 closed out, a net change of +12 holders.
- The largest Collegium Pharmaceutical buyer in Q3 2022 was Janus Henderson Group, an estimated $28.6M added.
- The largest Collegium Pharmaceutical seller in Q3 2022 was Royce & Associates, an estimated $7.62M sold.
Based on aggregated 13F filings for Q3 2022.